GLPGCP Development (Asia) Pte. Ltd.June 22, 2017

FDA 483 - GLPGCP Development (Asia) Pte. Ltd. - June 22, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GLPGCP Development (Asia) Pte. Ltd.

Record Details

An FDA inspection of GPC Medical Ltd. in New Delhi, India, revealed significant deficiencies in their quality system for device manufacturing. The firm was cited for inadequate procedures concerning labeling activities, process validation, and the acceptance and control of both in-process and finished devices. These observations highlight a need for comprehensive improvements in their operational controls.

Company: GLPGCP Development (Asia) Pte. Ltd.
Inspection Date: June 22, 2017
Product Type: Devices
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: Andrea A. Branche (CSO)

Open in Dashboard

ID · 8bad919d-c1b6-4fee-b805-fadc9ef0faa4